title: Telmisartan, ramipril, or both in patients at high risk of vascular events.
authors.forename: Nikolaus
authors.initials: N
authors.lastname: Büchner
authors.forename: Bernhard
authors.initials: B
authors.lastname: Banas
authors.forename: Bernhard K
authors.initials: BK
authors.lastname: Krämer
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000401:mortality; D002423:Cause of Death; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D017257:Ramipril / Q000627:therapeutic use*; D000077333:Telmisartan
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001565:Benzoates; D017257:Ramipril; D000077333:Telmisartan